278 related articles for article (PubMed ID: 31730533)
1. Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders.
Penzhoyan GA; Makukhina TB
J Perinat Med; 2019 Dec; 48(1):21-26. PubMed ID: 31730533
[TBL] [Abstract][Full Text] [Related]
2. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
[TBL] [Abstract][Full Text] [Related]
3. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta.
Büke B; Akkaya H; Demir S; Sağol S; Şimşek D; Başol G; Barutçuoğlu B
J Matern Fetal Neonatal Med; 2018 Jan; 31(1):59-62. PubMed ID: 28027672
[TBL] [Abstract][Full Text] [Related]
4. Lower uterine segment scar assessment at 11-14 weeks' gestation to screen for placenta accreta spectrum in women with prior Cesarean delivery.
Bhatia A; Palacio M; Wright AM; Yeo GSH
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):40-48. PubMed ID: 34254386
[TBL] [Abstract][Full Text] [Related]
5. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation.
Thompson O; Otigbah C; Nnochiri A; Sumithran E; Spencer K
BJOG; 2015 Sep; 122(10):1370-6. PubMed ID: 25639820
[TBL] [Abstract][Full Text] [Related]
6. Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes.
Balkaş G; Çaglar T
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9955-9961. PubMed ID: 37916365
[TBL] [Abstract][Full Text] [Related]
7. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.
Wang F; Chen S; Wang J; Wang Y; Ruan F; Shu H; Zhu L; Man D
Arch Gynecol Obstet; 2021 Mar; 303(3):645-652. PubMed ID: 33515274
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
[TBL] [Abstract][Full Text] [Related]
9. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy.
Abinader RR; Macdisi N; El Moudden I; Abuhamad A
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):457-464. PubMed ID: 34837427
[TBL] [Abstract][Full Text] [Related]
10. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
[TBL] [Abstract][Full Text] [Related]
11. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
12. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening.
Timofeeva AV; Fedorov IS; Suhova YV; Tarasova AM; Ezhova LS; Zabelina TM; Vasilchenko ON; Ivanets TY; Sukhikh GT
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255950
[TBL] [Abstract][Full Text] [Related]
14. Prospective First-Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum.
Happe SK; Rac MWF; Moschos E; Wells CE; Dashe JS; McIntire DD; Twickler DM
J Ultrasound Med; 2020 Oct; 39(10):1907-1915. PubMed ID: 32374433
[TBL] [Abstract][Full Text] [Related]
15. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders.
Yu FNY; Leung KY
Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():13-24. PubMed ID: 32747328
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of distal haemostasis during caesarean delivery in women with placenta accreta spectrum disorders.
Barinov SV; Shmakov RG; Medyannikova IV; Tirskaya YI; Kadtsyna TV; Lazareva OV; Razdobedina IN; Neustroyeva TN; Stepanov SS
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8778-8785. PubMed ID: 34794371
[TBL] [Abstract][Full Text] [Related]
17. Trimester-specific diagnostic accuracy of ultrasound for detection of placenta accreta spectrum: systematic review and meta-analysis.
Hessami K; Horgan R; Munoz JL; Norooznezhad AH; Nassr AA; Fox KA; Di Mascio D; Caldwell M; Catania V; D'Antonio F; Abuhamad AZ
Ultrasound Obstet Gynecol; 2024 Jun; 63(6):723-730. PubMed ID: 38324675
[TBL] [Abstract][Full Text] [Related]
18. Elevated first trimester PAPP--a is associated with increased risk of placenta accreta.
Desai N; Krantz D; Roman A; Fleischer A; Boulis S; Rochelson B
Prenat Diagn; 2014 Feb; 34(2):159-62. PubMed ID: 24226752
[TBL] [Abstract][Full Text] [Related]
19. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
[TBL] [Abstract][Full Text] [Related]
20. First trimester serum PIGF is associated with placenta accreta.
Wang F; Zhang L; Zhang F; Wang J; Wang Y; Man D
Placenta; 2020 Nov; 101():39-44. PubMed ID: 32916477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
